| __timestamp | Grifols, S.A. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 2704597 |
| Thursday, January 1, 2015 | 224193000 | 15470000 |
| Friday, January 1, 2016 | 197617000 | 28037000 |
| Sunday, January 1, 2017 | 288320000 | 71615000 |
| Monday, January 1, 2018 | 240661000 | 99828000 |
| Tuesday, January 1, 2019 | 276018000 | 166023000 |
| Wednesday, January 1, 2020 | 294216000 | 201727000 |
| Friday, January 1, 2021 | 354881000 | 259039000 |
| Saturday, January 1, 2022 | 361140000 | 294781000 |
| Sunday, January 1, 2023 | 330551000 | 344077000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is key. Grifols, S.A. and Iovance Biotherapeutics, Inc. are two companies that have consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, Grifols has shown a steady increase in R&D spending, peaking in 2022 with a 100% increase from 2014. Meanwhile, Iovance Biotherapeutics has demonstrated a more dramatic growth trajectory, with R&D expenses skyrocketing by over 12,000% during the same period. By 2023, Iovance surpassed Grifols in R&D investment, highlighting its aggressive push towards innovation. This trend underscores the dynamic nature of the biotech industry, where strategic investments in R&D can redefine market positions. As these companies continue to innovate, their commitment to R&D will likely shape the future of healthcare solutions.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
R&D Insights: How AstraZeneca PLC and Grifols, S.A. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Grifols, S.A. vs Verona Pharma plc
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and PTC Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?